Chrome 2001
.
The Trusted Source InteliHealth Aetna InteliHealth Aetna InteliHealth
Enter Drug Name . Enter Search Term
     
. .
. .
.
Home
Health Commentaries
InteliHealth Dental
Drug Resource Center
Ask the Expert
Interactive Tools

InteliHealth Policies
Site Map
Diseases & Conditions Healthy Lifestyle Your Health Look It Up
Health News Health News
.
Associated Press

Feds Probe Tainted Medical Research
December 28, 2001

WASHINGTON (AP) - Universities and federal health officials must do more to prevent financial conflicts that could taint biomedical research and harm human subjects, a congressional review says.

The study by the General Accounting Office, the investigative arm of Congress, said researchers do not have to disclose their financial interests to independent review boards, even though the boards must evaluate projects for risks to human subjects.

The GAO found the five universities it studied were hard-pressed to provide basic data about researchers' financial conflicts of interest in clinical studies involving humans.

Sen. Bill Frist, R-Tenn., requested the investigation because of concerns that researchers or institutions were becoming too focused on financial rewards. Frist is a physician.

The report said the universities kept information about research activities and financial interests in different offices and in different formats, ``making it a challenge to ensure that conflicts of interest were appropriately managed and not overlooked.''

Officials at some of the universities told the GAO that they were beginning to develop a central database for financial information.

Collaborations between government-funded researchers and private industry have increased. A 1980 law let universities, nonprofit corporations and small businesses keep the patents and profits from their federally funded projects.

The budget of the National Institutes of Health, the main federal agency that funds biomedical research, grew from more than $3 billion in 1980 to more than $20 billion this year. Funding from drug companies grew even more rapidly, from $1.5 billion in 1980 to $22.4 billion in 2000.

The report said the five universities had developed policies for financial conflicts of interest, but they were all different.

The GAO recommended that federal health officials improve oversight and regulations governing financial interest, and to help institutions identify and manage such conflicts.

Health and Human Services officials agreed with the report's findings, and said efforts are under way to visit institutions to collect data and to analyze their conflict policies.

The universities studied were the University of California, Los Angeles; University of North Carolina, Chapel Hill; University of Washington in Seattle; Washington University in St. Louis; and Yale University.

Copyright 2001 The Associated Press. All rights reserved.

.
InteliHealth
. . . .
.
More News
InteliHealth .
.
Top News
General Health
This Week In Health
Addiction
Allergy
Alzheimer's
Asthma
Arthritis
Babies
Breast Cancer
Cancer
Caregiving
Cervical Cancer
Children's Health
Cholesterol
Complementary & Alternative Medicine
Dental / Oral Health
Depression
Diabetes
Ear, Nose And Throat
Eyes
Family Health
Fitness
Headache
Heart Health
HIV / AIDS
Infectious Diseases
Lung Cancer
Medications
Men's Health
Mental Health
Nutrition News
Multiple Sclerosis
Nutrition Guide
Parkinson's
Pregnancy
Prevention
Prostate Cancer
Senior Health
Sexual / Reproductive Health
Sleep
Tobacco Cessation
STDs
Stress Reduction
Stroke
Weight Management
Today In Health History
Women's Health
Workplace Health
.
.
.
.
InteliHealth

   
.
.   HONcode
.
Chrome 2001
Chrome 2001